Cargando…

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record

A meeting among expert pathologists was held in 2019 in Rome to verify the results of the previous harmonization efforts on the PD-L1 immunohistochemical testing by scoring a representative series of non-small cell lung cancer (NSCLC) digital slides. The current paper shows the results of this digit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagni, Fabio, Malapelle, Umberto, Doglioni, Claudio, Fontanini, Gabriella, Fraggetta, Filippo, Graziano, Paolo, Marchetti, Antonio, Guerini Rocco, Elena, Pisapia, Pasquale, Vigliar, Elena V., Buttitta, Fiamma, Jaconi, Marta, Fusco, Nicola, Barberis, Massimo, Troncone, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408471/ https://www.ncbi.nlm.nih.gov/pubmed/32635634 http://dx.doi.org/10.3390/cancers12071800

Ejemplares similares

Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
por: Guerini Rocco, Elena, et al.
Publicado: (2022)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017)

Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
por: Malapelle, Umberto, et al.
Publicado: (2016)

Digital Slides as an Effective Tool for Programmed Death Ligand 1 Combined Positive Score Assessment and Training: Lessons Learned from the “Programmed Death Ligand 1 Key Learning Program in Head-and-Neck Squamous Cell Carcinoma”
por: Eccher, Albino, et al.
Publicado: (2021)

Cytology in the time of coronavirus disease (COVID-19): an Italian perspective
por: Vigliar, Elena, et al.
Publicado: (2021)

A narrative review of lung cancer cytology in the times of coronavirus: what physicians should know
por: Pisapia, Pasquale, et al.
Publicado: (2020)

Next generation sequencing in cytology
por: Pisapia, Pasquale, et al.
Publicado: (2021)

BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report
por: Pepe, Francesco, et al.
Publicado: (2021)

Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

KRAS mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting
por: Nacchio, Mariantonia, et al.
Publicado: (2020)

Understanding EGFR heterogeneity in lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020)

Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network
por: Marchetti, Antonio, et al.
Publicado: (2021)

EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
por: Pisapia, Pasquale, et al.
Publicado: (2019)

A roadmap for a comprehensive diagnostic approach to fine needle cytology of lymph node metastases
por: Acanfora, Gennaro, et al.
Publicado: (2022)

Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic
por: Palladino, Raffaele, et al.
Publicado: (2020)

BRAF: A Two-Faced Janus
por: Pisapia, Pasquale, et al.
Publicado: (2020)

PD‐L1 and beyond: Immuno‐oncology in cytopathology
por: Iaccarino, Antonino, et al.
Publicado: (2021)

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
por: Pagni, Fabio, et al.
Publicado: (2019)

Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine needle aspiration of neck paraganglioma
por: Carillo, Anna Maria, et al.
Publicado: (2022)

The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience
por: Vigliar, Elena, et al.
Publicado: (2019)

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
por: Bruera, Gemma, et al.
Publicado: (2018)

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
por: Fusco, Nicola, et al.
Publicado: (2020)

The molecular landscape of breast mucoepidermoid carcinoma
por: Venetis, Konstantinos, et al.
Publicado: (2023)

Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting
por: Malapelle, Umberto, et al.
Publicado: (2021)

Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial
por: Rocco, Danilo, et al.
Publicado: (2019)

Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
por: Della Corte, Carminia Maria, et al.
Publicado: (2017)

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
por: Corte, Carminia Maria Della, et al.
Publicado: (2022)

RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer
por: De Luca, Caterina, et al.
Publicado: (2021)

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence
por: Attili, Ilaria, et al.
Publicado: (2022)

Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations
por: Marchetti, Antonio, et al.
Publicado: (2022)

The Treatment of Advanced Melanoma: Therapeutic Update
por: Villani, Alessia, et al.
Publicado: (2022)

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments
por: Marchetti, Antonio, et al.
Publicado: (2019)

Full cost of diagnostic pathology for lung carcinoma in Italy: results from four Pathology Units
por: Lazzaro, Carlo, et al.
Publicado: (2023)

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
por: Angerilli, Valentina, et al.
Publicado: (2021)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
por: Pisapia, Pasquale, et al.
Publicado: (2021)

FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint
por: Cappello, Filippo, et al.
Publicado: (2022)

Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study
por: Malapelle, Umberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uhf82utg54dt8kkhfo0eftmdag